Osilodrostat and steroid replacement for Cushing syndrome
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new approach, called 'block-and-replace', for treating Cushing syndrome. You will take osilodrostat to lower high cortisol levels, along with a glucocorticoid (a steroid) to replace what your body needs. This study may help control the disease if surgery hasn't worked or isn't an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Cushing syndrome caused by your body making too much cortisol (endogenous Cushing syndrome).
- Your doctor is already considering osilodrostat as part of your treatment.
- You have had surgery for Cushing syndrome that didn't fix it, or you are not able to have surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medication (osilodrostat) combined with a special PET scan can help find tiny pituitary tumors in people with Cushing's disease when MRI shows nothing or something unclear. It may help guide surgery or other treatments.
This trial compares two medications, hydrocortisone and methylprednisolone, to see which works better for people whose adrenal glands have stopped working properly after taking high doses of steroids (methylprednisolone) for more than 4 weeks.
This study tests a new wearable biosensor that measures steroid hormone levels in your skin fluid. It may help doctors better manage adrenal conditions by continuously monitoring cortisol and aldosterone without blood draws.
This trial tests whether hydrocortisone (a cortisol replacement) helps people who feel symptoms of adrenal insufficiency after they stop long-term prednisolone. It compares hydrocortisone versus placebo to see if symptoms improve and dosing is safer/effective.
This study tests a new medicine called Lu AG13909 for adults with Cushing's disease caused by a pituitary tumor. It aims to see if the medicine can lower cortisol levels and help control the disease.
This trial tests whether osilodrostat can lower blood pressure in people with Cushing's syndrome whose high blood pressure is not well controlled by their current medications. The drug works by reducing the production of the stress hormone cortisol, which is abnormally high in Cushing's syndrome.
Hear when a new Adrenal Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.